Steven Valiquette

“My question here is regarding the potential monetization of the Prospect managed care business. I'm trying to better understand the new binding commitment from a third-party lender versus the potential managed care transaction that was under negotiation previously.”

“So there was a lot of discussion back around the time of the merger and the announcement of merger closed around revenue synergy potential from the deal. Just a couple of questions around that.”

“So just the question here around — just healthcare REITs in general with skilled nursing assets this quarter, I think it's brought a pretty wide array of strategic updates in the various companies.”

“So there was so much focus over the past year on the $1.80 EPS headwind for the Company related to COVID in 2021. Is the $1.80 essentially where that final number shook out for last year?”

“So one common theme that we’ve seen across some of the publicly-traded hospital operators recently is that a higher acuity patient mix is more than offsetting the admission declines relative to the pre-COVID baseline.”